RABV G (linear epitope) Specific Neutra™ Antibody (V3S-0923-CJ21), Mouse IgG (CAT#: V3S-0923-CJ21)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target
Virus Background

Summary

Description This recombinant anti-RABV G antibody (clone 15-13) is against the sequential epitopes on Rabies virus (RABV) glycoprotein G.
Clonality Monoclonal
Host Species Mouse
Target Species Rabies virus (RABV)
Epitope The sequential epitope on RABV glycoprotein G
Affinity KD = 5.6 nM (Fab)
KD = 24.9 nM (VH-VL scFv)
KD = 17.7 nM (VL-VH scFv)
Isotype Mouse IgG

Property

Expression Species HEK293F or CHO cell line
Conjugation Unconjugated
Purity >95%
Endotoxin <1 EU/mg
Form Liquid
Purification Protein G purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within a week. For longer storage, aliquot and store at -20°C.

Applications

Application Neut
Application Notes The antibody 15-13, recognizing the sequential epitopes, shows neutralization activity to RABVG.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target RABV G
Alternative Name Rabies virus; rabies virus glycoprotein; RABV glycoprotein
Gene ID 1489856
UniProt P08667
Research Area Cell Biology; Microbiology
Related Disease Rabies

Virus Background

Post Translational Modification Glycosylated and palmitoylated by host. Glycosylation is crucial for glycoprotein export at the cell surface (By similarity).
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
ISO 9001 Certified - Creative Biolabs Quality Management System.
Online Inquiry